US Broker Ratings

ACADIA Pharmaceuticals Inc. (ACAD) Investor Outlook: A 51.74% Potential Upside Awaits as Biotech Innovates in Neurological Treatments

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a San Diego-based biopharmaceutical company specializing in neurological and rare diseases, presents a compelling opportunity for individual investors seeking growth in the healthcare sector. With..

Belite Bio, Inc (BLTE) Stock Analysis: Exploring a Potential 39.94% Upside in Biotech Innovation

Belite Bio, Inc (NASDAQ: BLTE), a pioneering name in the biotechnology sector, is capturing investor attention with its innovative approach to treating retinal degenerative diseases. Based in San Diego, California,..

Alignment Healthcare, Inc. (ALHC) Stock Analysis: A 45.63% Upside Potential Sparks Investor Interest

Alignment Healthcare, Inc. (ALHC) is steadily attracting attention in the healthcare sector with its innovative approach to senior care through Medicare Advantage plans. Based in Orange, California, the company has..

Kymera Therapeutics, Inc. (KYMR) Stock Analysis: A Biotech Powerhouse with 54.81% Potential Upside

Kymera Therapeutics, Inc. (NASDAQ: KYMR), a prominent player in the biotechnology sector, is capturing investor attention with its innovative approach to drug development and compelling growth potential. Based in Watertown,..

Galapagos NV (GLPG) Stock Analysis: Revenue Boom Amidst Biotech Challenges

Galapagos NV (GLPG), a prominent player in the biotechnology sector, has captured investor attention with its impressive revenue growth and strategic focus on oncology and immunology. Headquartered in Mechelen, Belgium,..

Catalyst Pharmaceuticals, Inc. (CPRX) Stock Analysis: A Biotech Contender with 45.80% Upside Potential

Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) is a name that biotech investors should keep on their radar. With a significant market capitalization of $2.87 billion and a strong presence in the..

Denali Therapeutics Inc. (DNLI) Stock Analysis: Exploring a 56% Potential Upside in Biotech Innovation

As Denali Therapeutics Inc. (NASDAQ: DNLI) navigates the complex landscape of biotechnology, investors are taking note of the company’s promising pipeline and significant market potential. Specializing in the treatment of..

Ardent Health, Inc. (ARDT) Stock Analysis: Exploring the 47% Upside Potential

Ardent Health, Inc. (NYSE: ARDT) operates an expansive network of hospitals and clinics across the United States, positioning itself as a significant player in the healthcare sector. Despite facing challenges..

Haemonetics Corporation (HAE) Stock Analysis: Exploring a 49.67% Potential Upside in the Medical Device Sector

Haemonetics Corporation (NYSE: HAE), a prominent player in the healthcare sector, is a medical technology company with a strong presence in the medical devices industry. With a market capitalization of..

HUTCHMED (China) Limited (HCM): Growth Potential with a 53% Upside and Strong Analyst Support

HUTCHMED (China) Limited (HCM), a prominent player in the healthcare sector, particularly within the drug manufacturing industry, is capturing investor attention with its potential growth trajectory and robust analyst endorsement...

Organon & Co. (OGN) Stock Analysis: Understanding the 47.78% Potential Upside in a Turbulent Market

As investors explore the dynamics of the healthcare sector, Organon & Co. (NYSE: OGN) presents a compelling narrative. With its roots in Jersey City, New Jersey, Organon has carved out..

Arcellx, Inc. (ACLX) Stock Analysis: Navigating the Biotech Landscape with a $6.7 Billion Market Cap

Arcellx, Inc. (ACLX), a rising star in the biotechnology sector, is making waves with its ambitious pipeline focused on innovative immunotherapies. Headquartered in Redwood City, California, Arcellx is carving its..

Alvotech (ALVO) Stock Analysis: Exploring a 365% Upside Potential in the Biosimilar Market

Alvotech (NASDAQ: ALVO), a Luxembourg-based healthcare company specializing in biosimilar medicines, presents a compelling opportunity for investors seeking exposure to the burgeoning biosimilars market. With a market capitalization of $1.04..

MoonLake Immunotherapeutics (MLTX) Stock Analysis: Exploring a 53% Upside Potential

MoonLake Immunotherapeutics (NASDAQ: MLTX), a clinical-stage biotechnology company headquartered in Zug, Switzerland, is garnering attention for its innovative approach to treating inflammatory skin and joint diseases. With a market capitalization..

LifeStance Health Group, Inc. (LFST) Stock Analysis: Exploring a Promising 50% Upside Potential

LifeStance Health Group, Inc. (NASDAQ: LFST), a prominent player in the healthcare sector, specifically within the medical care facilities industry, is capturing investor attention with its compelling growth narrative and..

Privia Health Group, Inc. (PRVA) Stock Analysis: Exploring a 48% Upside Potential in the Healthcare Sector

Privia Health Group, Inc. (NASDAQ: PRVA) stands at the forefront of the healthcare sector, providing innovative solutions within the health information services industry. With a market capitalization of $2.66 billion,..

Apogee Therapeutics (APGE) Stock Analysis: Strong Buy Ratings and a 31.67% Upside Potential

Apogee Therapeutics, Inc. (NASDAQ: APGE), a clinical-stage biotechnology firm, is attracting significant attention from investors, thanks to its innovative pipeline and promising analyst ratings. With a market capitalization of $5.46..

Xenon Pharmaceuticals Inc. (XENE) Stock Analysis: Unpacking the 45% Potential Upside in Biotech

Xenon Pharmaceuticals Inc. (NASDAQ: XENE) is making waves in the biotechnology sector with its promising pipeline of neurological and psychiatric treatments. The Canadian company, boasting a market capitalization of $5.19..

Scholar Rock Holding Corporation (SRRK) Stock Analysis: A Biotech with Promising 28.43% Upside Potential

Scholar Rock Holding Corporation (NASDAQ: SRRK) is capturing investor attention with its considerable potential upside of 28.43%, according to analyst ratings. As a biopharmaceutical company dedicated to transforming the treatment..

ICU Medical, Inc. (ICUI) Stock Analysis: Exploring a 40.59% Potential Upside with Strong Buy Ratings

ICU Medical, Inc. (NASDAQ: ICUI), a stalwart in the healthcare sector specializing in medical instruments and supplies, has piqued investor interest with its promising growth potential. The company, headquartered in..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds